Leukemia Clinical Trials

Showing 6021-6040 of 10,987 trials

A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors

NCT05105464

This is a multi-center, open-label, dose escalation and expansion, phase I study to investigate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) characteristics, preliminary efficacy of SYHA1815 in subjects with unresectable locally advanced or metastatic solid tumors. Once the expected effective dose is identified, the dose expansion study will be started to further evaluate the safety, clinical activity and PK profile of SYHA1815 in subjects with unresectable locally advanced or metastatic solid tumors.

Locally Advanced Unresectable Carcinoma

Shanghai Runshi Pharmaceutical Technology Co., Ltd97 participantsStarted Jun 2021

Changchun, Jilin, China

COMPLETEDPhase 3

AR101 Real-World Open-Label Extension Study

NCT03337542

This study is enrolling participants by invitation only. This is an open-label, safety extension study for subjects who participated in the ARC007 study.

Peanut Allergy

Aimmune Therapeutics, Inc.243 participantsStarted Oct 2017

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +57 more locations

A Study to Investigate the Safety of SYHA1815 in Subjects With Unresectable Locally Advanced or Metastatic Solid Tumors

AR101 Real-World Open-Label Extension Study

Related Searches

Acute Myeloid Leukemia T Cell Depletion to Improve Transplants in Adults With Acute Myeloid Leukemia (BMT CTN 0303)

Treatment of Impending Ulcers Associated With Hammer, Mallet and Claw Toe Deformities in the Diabetic Patient Setting

Assessment of the Sub-gonal Arterial Revascularization of the Lower Limbs in Critical Ischemia by Venous Allograft Stored at + 4 ° C (ERAV)

Long-term Efficacy of Drug-coated Balloon Versus Drug-eluting Stent in Large de Novo Coronary Lesions

Treatment of Ulcers Associated With Hammer, Mallet and Claw Toe Deformities in the Diabetic Patient Setting

Jinfukang Oral Liquid Combined With Chemotherapy for Treating Driver Gene-negative Advanced NSCLC

Haematopoietic Stem Cell Transplantation (HSCT) in Comparison to Conventional Consolidation Therapy for Patients With Acute Myeloid Leukemia (AML) (Intermediate Risk) </= 60y. After First CR

Pharmacokinetics of Venetoclax in Patients With Chronic Lymphocytic Leukemia

Artificial Intelligence in Diagnosing Dysphagia Patients

Pharmacokinetics of Venetoclax in Patients With Acute Myeloid Leukemia

Venetoclax Combining With Fludarabine and Melphalan as Conditioning Regimen for Allo-HSCT

The Feasibility of Systemic Reaction After Contact Exposure to the Allergenic Food in Children With Known Food Allergy

Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome and Neutropenia

A Clinical Study of Chinese Domestic Surgical Robot

Intranasal Dexmedetomidine Sedation at Dose of 2 mcg/kg Versus 4 mcg/kg in Children Undergoing MRI

A Study for PRO of CML in Real Word

Methyl-qPCR : a New Predictive Marker for Epstein-Barr Virus-associated Lymphoproliferations During Allogeneic Hematopoietic Stem Cell Transplantation

Developpement of 3T MRI Protocol